MAXCAPs

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMAXCAPs
Drug Alias NameMAXCAPs
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCaspase-3 inhibitorsCaspase inhibitors
TargetsCaspase-3Caspase
Therapy Area/IndicationsHepatitis, AlcoholicMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California At Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California At Los AngelesSalix Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsHepatitis, AlcoholicMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A